Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

124
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
124
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

221
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
221
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

419
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
419
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
Survival Tree01:19

Survival Tree

80
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
80

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Robust Modestly Weighted Log-Rank Tests.

Pharmaceutical statistics·2025
Same author

A Bayesian design for dual-agent dose optimization with targeted therapies.

Journal of biopharmaceutical statistics·2025
Same author

Optimal risk-assessment scheduling for primary prevention of cardiovascular disease.

Journal of the Royal Statistical Society. Series A, (Statistics in Society)·2025
Same author

Estimating the Variance of Covariate-Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary Endpoints.

Pharmaceutical statistics·2025
Same author

Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study.

BMJ public health·2025
Same author

Modeling synergism in early phase cancer trials with drug combination with continuous dose levels: is there an added value?

Brazilian journal of biometrics·2024
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
查看所有相关文章

相关实验视频

Updated: Jun 27, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

在预期的延迟效应下,对生存分析中的可视化假设测试.

José L Jiménez1, Isobel Barrott2, Francesca Gasperoni1

  • 1Novartis Pharma A.G., Basel, Switzerland.

Pharmaceutical statistics
|May 6, 2024
PubMed
概括
此摘要是机器生成的。

对于具有延迟效果的随机临床试验,选择正确的统计方法至关重要. 本研究引入了一种图形方法,用于比较加权日志等级测试和限制平均生存时间 (RMST),以便更好地分析.

关键词:
延迟的效果 延迟的效果伪价值是一个假价值.球队的成绩 球队的成绩 球队的成绩生存测试 测试 生存测试视觉化的可视化

更多相关视频

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.4K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.4K

相关实验视频

Last Updated: Jun 27, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.4K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.4K

科学领域:

  • 生物统计学 生物统计学
  • 临床试验 临床试验
  • 生存分析的分析.

背景情况:

  • 标准的统计方法,如日志等级测试和考克斯模型,可能不适合随机临床试验 (RCT) 随时到事件终点,当由于延迟治疗效应预计存在不成比例的风险时.
  • 最近的统计文献已经探索了替代方法,包括加权的日志等级测试和基于限制平均生存时间 (RMST) 的测试.

研究的目的:

  • 解决关于RCT与时间到事件数据和延迟效应的适当统计方法的辩论.
  • 引入一种新的图形方法来比较不同的统计方法.
  • 为了促进分析方法的更明智的选择,超越传统的功率和I型错误的考虑.

主要方法:

  • 权衡日志等级测试和基于受限平均生存时间 (RMST) 的测试的比较.
  • 引入图形方法,直接比较这些统计方法.
  • 在各种条件下评估不同方法的功率和I型错误特征.

主要成果:

  • 权衡的日志级别测试可以提供高功率,但可能会增加I型错误率,并且缺乏明确的总结措施.
  • 基于RMST的测试提供了数学上明确的总结措施,但可能无法完全捕捉长期治疗益处.
  • 拟议的图形方法允许对这些方法进行更细致的比较.

结论:

  • 对于具有延迟效果的RCT的统计方法的选择需要仔细考虑标准方法之外的其他方法.
  • 图形比较工具有助于根据特定试验特征选择最合适的方法.
  • 这项工作有助于提高临床试验中时间到事件分析的统计学严谨性和解释性.